The Board of Directors in its 104th Meeting held on 30 June 2019 at 3.30 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 is pleased to declare the commencement of Commercial Production of its state-of-the-art Steroid and Hormone facility at Dhulivita, Dhamrai, Dhaka after successful completion of trail production.
It should be noted here that the last Annual General Meeting(AGM) of the Company, it was unanimously approved by the Shareholders that two projects out of three projects against which the fund was raised through Initial Public Offering (IPO) namely (1) Penicillin and (2) Steroid and Hormone projects will start commercial production within 30 June 2019. Accordingly, Penicillin project has already been started commercial production on 12 June 2019 for which necessary Price Sensitive Information (PSI) was published within the time limit. Now, the second project e.g. Steroid and Hormone project has been approved for commencement of commercial production.